Clinical trials in Dordrecht – page 34

1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Dordrecht at a glance

1 624

clinical trials

Research sites1

Quick filters

1 624 trials in Dordrecht

Open in trial search

Myocardial infarction

Recruiting

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Research Maatschap Cardiologen Rotterdam Zuid

Contact Research Centre

Procedural pain

Recruiting

Study on Preventing Chronic Pain After Hernia and Knee Surgery Using Tapentadol for Patients Undergoing These Surgeries

Registered drugNo placebo

Study on Preventing Chronic Pain After Hernia and Knee Surgery Using Tapentadol for Patients Undergoing These Surgeries

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tapentadol Hydrochloride
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Peripheral artery restenosis+4

Recruiting

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Registered drug

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Thermal burn

Recruiting

Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

InvestigationalNo placebo

Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Sponsor:Cutiss AG

Contact Research Centre

Plasma cell myeloma

Recruiting

Study on Reducing Oral Side Effects of Talquetamab in Multiple Myeloma Patients Using Pregabalin, Dexamethasone, and Clonazepam

Registered drugNo placebo

Study on Reducing Oral Side Effects of Talquetamab in Multiple Myeloma Patients Using Pregabalin, Dexamethasone, and Clonazepam

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Clonazepam
Sponsor:Janssen Cilag International

Contact Research Centre

Acute leukaemia

Recruiting

Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

InvestigationalNo placebo

Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Revumenib
Sponsor:Syndax Pharmaceuticals Inc.

Contact Research Centre

Myasthenia gravis

Recruiting

Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

Registered drugNo placebo

Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Malignant glioma

Recruiting

Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

InvestigationalNo placebo

Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Tovorafenib
Sponsor:Day One Biopharmaceuticals Inc.

Contact Research Centre

Plasma cell myeloma

Recruiting

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bortezomib
Sponsor:Pfizer Inc.

Contact Research Centre

Crohn's disease

Recruiting

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

The Netherlands

Participants:0–17 years
Substances:Mirikizumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Bone hypertrophy

Recruiting

Study of Pamidronate for Pain Relief in Patients with Sternocostoclavicular Hyperostosis (SCCH)

Registered drug

Study of Pamidronate for Pain Relief in Patients with Sternocostoclavicular Hyperostosis (SCCH)

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pamidronate Disodium
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

Registered drugNo placebo

Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dabrafenib Mesylate
Sponsor:Novartis Pharma AG

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Dordrecht

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.

Blood Cancer Therapies
Leukemia Treatment
Novel Drug Combinations

Studies aim to improve survival rates and treatment outcomes in previously untreated patients.

02 Cardiovascular Medicine

Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.

Heart Disease Management
Blood Clot Prevention
Cardiac Interventions

Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.

03 Endocrine Disorders

Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.

Thyroid Disease Management
Hormone Therapy
Quality of Life Improvement

Research aims to enhance treatment efficacy while minimizing side effects.

Back to the Netherlands All countries